SCHEMBL26686209

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL30633357	1.00	FLT1 (0.47)	FLT1TEKJAK2GCKEGFR
	SCHEMBL30633297	0.89	MEN1 (0.48)	JAK2KDRMAPK1JAK1KIT
	SCHEMBL26686298	0.89	MEN1 (0.48)	JAK2KDRMAPK1JAK1KIT
	SCHEMBL30633352	0.89	JAK2 (0.56)	FLT1JAK2EGFRKDRMAPK1
	SCHEMBL26685861	0.89	JAK2 (0.56)	FLT1JAK2EGFRKDRMAPK1
	SCHEMBL31240330	0.88	JAK2 (0.50)	JAK2EGFRBTKKDRJAK1
	SCHEMBL31420124	0.85	JAK2 (0.61)	FLT1JAK2EGFRKDRMAPK1
	SCHEMBL26686370	0.85	JAK2 (0.61)	FLT1JAK2EGFRKDRMAPK1
	SCHEMBL30633302	0.85	F10 (0.46)	FLT1JAK2EGFRKDRMAPK1
	SCHEMBL26686210	0.85	F10 (0.46)	FLT1JAK2EGFRKDRMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.